Company Overview and News

 
PRESS DIGEST- Canada-Sept 21

15h reuters
Sept 21 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
TORSF

 
Torstar to buy political news outlet iPolitics

2018-09-20 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
TORSF

 
Toys "R" Us Canada still very much alive, after tumultuous year in which U.S., U.K. units folded

2018-08-24 cbc.ca
Toys "R" Us Canada's president says most of the people she has met with over the past tumultuous year have asked her the same question, "Have you found another job?"
FXFLF FXFHF FAXXF FRFZF TORSF FRFXF FAXRF FRFHF FRFGF FRFFF

 
Torstar Corp. (TORSF) CEO John Boynton on Q2 2018 Results - Earnings Call Transcript

2018-08-05 seekingalpha
Good morning, ladies and gentlemen. Welcome to the Torstar Corporation Q2 2018 Results Conference Call. Please be advised that today's call is being recorded. Your speakers for today are Mr. John Boynton, President and CEO of Torstar Corporation and Publisher Toronto Star; and Mr. Lorenzo DeMarchi, Executive Vice President and CFO of Torstar Corporation.
TORSF

 
David Olive: Torstar sees progress in digital transformation plan

2018-08-01 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
TORSF

 
Metrolinx head resigns citing election of new government as right time for change of leadership

2018-07-12 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
TORSF

 
Postmedia reports $15.5 million loss as quarterly revenue slips

2018-07-11 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
PNC.A PNC.B TORSF

 
Torstar is cutting 11 full-time, 10 part-time staff at StarMetro in Toronto

2018-06-29 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
TORSF

6
PRESS DIGEST- Canada-May 10

2018-05-10 reuters
May 10 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
KMI TORSF KMR KMRFZ CVB

 
Torstar plans further transformation amid tough print advertising market: CEO

2018-05-09 cbc.ca
Torstar Corp. is preparing to invest in multiple initiatives to transform its core business amid a challenging print advertising market, company officials said Wednesday after announcing first-quarter results.
TORSF 0550

 
Torstar reports lower loss in first quarter of 2018

2018-05-09 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
TORSF

 
Toronto Star brand to expand nationally

2018-04-02 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
TORSF

 
The voice of thestar.com is getting stronger

2018-04-02 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
TORSF

 
Toronto Star editor Michael Cooke to step down

2018-03-23 cbc.ca
The Toronto Star says editor Michael Cooke will step down on June 1 after more than nine years in the job.
TORSF

 
Documents detail allegations in Competition Bureau media investigation

2018-03-22 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
PNC.A PNC.B TORSF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...